PGP9.5 As a Candidate Tumor Marker for Non-Small-Cell Lung Cancer
Open Access
- 1 September 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (3) , 711-715
- https://doi.org/10.1016/s0002-9440(10)65169-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Landscaping the Cancer TerrainScience, 1998
- Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.Genes & Development, 1997
- NCI-navy medical oncology branch cell line data baseJournal of Cellular Biochemistry, 1996
- Microwave antigen retrieval for immunocytochemistry on formalin‐fixed, paraffin‐embedded post‐mortem CNS tissueThe Journal of Pathology, 1995
- PGP9.5, a ubiquitin C-terminal hydrolase; pattern of mRNA and protein expression during neural development in the mouseDevelopmental Brain Research, 1995
- The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogeneNature, 1993
- The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal HydrolaseScience, 1989
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987
- Molecular cloning of cDNA coding for human PGP 9.5 proteinFEBS Letters, 1987
- L-myc, a new myc-related gene amplified and expressed in human small cell lung cancerNature, 1985